—
C+
C+ The full Closelooknet — membership. Open the C+ overview

GALDERMA GROUP AG (GALDY) — the peer cohort

As of 2026-11-10 — scores re-bake nightly. Cohort = shared Closelooknet index membership first, then sector. Diary readings, not advice.

GALDERMA GROUP AG ranks 5 of 7 in its cohort on the Closelooknet composite (56/100) — the cohort is led by Laboratorios Farmaceuticos ROVI at 64/100.

NameCompositeMomentumQualityValuationSignalOff 52w high
GALDY GALDERMA GROUP AG 56 71 58 21 ok 4.4%
ROVI.MC Laboratorios Farmaceuticos ROVI 64 61 77 46 info 18.6%
IRWD Ironwood Pharmaceuticals Inc 60 69 77 83 info 16.8%
LNTH Lantheus Holdings Inc 59 69 73 53 ok 9.2%
KNSA Kiniksa Pharmaceuticals Ltd 58 94 61 17 ok 4.3%
ALM.MC Almirall S.A. 55 41 46 64 info 23.5%
AMRX Amneal Pharmaceuticals, Inc. Class A Common Stock 54 95 59 30 ok 1.4%

Scores are relative readings across the Closelooknet coverage universe — methodology in the company-scoring explainer. Signal lights come from the nightly signal board.

FAQ · from the current data · as of 2026-11-10

Quick answers

Who are GALDERMA GROUP AG's peers in the Closelooknet universe?

The cohort is drawn from shared Closelooknet index membership first, then sector: Laboratorios Farmaceuticos ROVI (ROVI.MC), Ironwood Pharmaceuticals Inc (IRWD), Lantheus Holdings Inc (LNTH), Kiniksa Pharmaceuticals Ltd (KNSA), Almirall S.A. (ALM.MC), Amneal Pharmaceuticals, Inc. Class A Common Stock (AMRX), as of 2026-11-10.

How does GALDY score against its peers?

GALDERMA GROUP AG's composite reads 56/100, ranking 5 of 7 in its cohort as of 2026-11-10; the cohort's highest composite is Laboratorios Farmaceuticos ROVI at 64/100. Closelooknet scores are research diary readings, not ratings or advice.

Related in the Closelooknet universe

then Drug Manufacturers - Specialty & Generic. Scored names rank on their Closelooknet score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.